Healthcare

Diagnostics are central to effective health care but still are not accessible to all. As Lancet 2020 study states 47% of the global population has little to no access to diagnostic, bringing in more emphasis equitable distribution across geographies and containing costs of procurement. During the pandemic there has been an increase in demand for p...

The rise in both global population and travel is contributing to the increase in spread of infectious diseases. Rapid and accurate identification of the infectious pathogens are imperative for timely intervention, better patient outcomes, and control and management of the spread of the infection. Conventional infectious disease diagnoses are perfor...

Hospitals are under extreme pressure to reduce costs and increase profits. Considering today’s uncertain regulatory climate and challenging economic environment, medical device companies are challenged to provide products and services to hospitals at an affordable cost. The operating room (OR) offers many opportunities to do so. ORs drive approxi...

A major challenge in drug discovery is the limited number of gene targets that can be targeted for the development of a drug molecule. Only close to 400 genes are proven targets for US FDA-approved drugs. 80% of human genes are unexplored as targets, and some are considered undruggable. The identification and the selection of novel drug targets (p...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) focuses on synthetic biology innovations around low cost gene synthesis and deployment of gene circuits for drug discovery and in therapies. Cell and gene therapies using logic gated circuits, along with early stage developers of gene circuits for drug discovery...

Health equity is achieved when all sections of the population have attained their full potential for health and well-being, regardless of cultural background or socioeconomic status. Inequities resulting from differences in health and overall living conditions need to be identified and removed to realize health equity. Monitoring health inequity pa...

08 Jun 2022  |  North America

Growth Opportunities in Sterile Injectable Outsourcing

Biologics Drive the Future Growth Potential of Sterile Injectable Outsourcing

Infographics

×

Injectables constitute one of the fastest growing segments in the pharmaceuticals space. Many drugs, including biologics, are going off patent in next 3 or 4 years, which will lead to an increase in the demand for generics and biosimilar injectables. The increase in onshoring and nearshoring of biopharmaceutical products for COVID-19 and next-gen...

31 May 2022  |  North America

Global RNA Therapeutics Growth Opportunities

Future Growth Potential Driven by Co-Development Programs and Robust Clinical Trials for Diverse Disease Areas

Infographics

×

Scientific advancements in nucleic acid-based therapies have significantly impacted the global biopharmaceutical industry. The ribonucleic acid (RNA) therapeutics market is expected to witness remarkable clinical progress as therapies target “undruggable” pathways. Technologically advanced platforms are integrated into RNA therapeutics bioproce...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical device and imaging industry. The issue includes drug delivery solution such as inhalational antibodies, vaccine and drug delivery using laser or sound waves, smart inhaler innovations such as precise delivery, sens...